˜yÐÄvlog

Advertisement

Advertisement

double-blind

[ duhb-uhl-blahynd ]

adjective

  1. of or relating to an experiment or clinical trial in which neither the subjects nor the researchers know which subjects are receiving the active medication, treatment, etc., and which are not: a technique for eliminating subjective bias from the test results.


double-blind

adjective

  1. of or relating to an experiment to discover reactions to certain commodities, drugs, etc, in which neither the experimenters nor the subjects know the particulars of the test items during the experiments Compare single-blind
“Collins English Dictionary — Complete & Unabridged†2012 Digital Edition © William Collins Sons & Co. Ltd. 1979, 1986 © HarperCollins Publishers 1998, 2000, 2003, 2005, 2006, 2007, 2009, 2012
Discover More

˜yÐÄvlog History and Origins

Origin of double-blind1

First recorded in 1935–40
Discover More

Compare Meanings

How does double-blind compare to similar and commonly confused words? Explore the most common comparisons:

Discover More

Example Sentences

Examples have not been reviewed.

The trial is a double-blind study, so no one knows who is on the drug and who is taking the placebo, with researchers monitoring changes in iron levels in all participants.

From

“Although there are many hangover products marketed, there is no convincing scientific evidence that these treatments are effective. Independent double-blind, placebo-controlled clinical trials in social drinkers are needed,†Verster said.

From

While several randomized, double-blind, multicenter phase II or III trials published in the past 20 years support the concept that even a single dose of cell products has beneficial effects in patients with heart failure on optimal medical therapy, the ongoing trial are taking novel directions, Zhang says.

From

As a double-blind, double-dummy, active-comparator placebo-controlled trial, neither the people in the study, or the study investigators knew which study arm or treatment they were given.

From

In the randomized, double-blind, Phase III clinical trial comparing the efficacy of the two medications, 99% of the participants in the Lenacapavir group did not acquire an HIV infection.

From

Advertisement

Advertisement

Advertisement

Advertisement